Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2930 | Placebo 0.20 mg + 2.00 mg/kg Wiki | 1.00 |
| drug2992 | Placebo- 2.00 mg/kg Wiki | 1.00 |
| drug1270 | Drug: GS-5734 - 2.00 mg/kg Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2990 | Placebo- 0.20 mg/kg Wiki | 1.00 |
| drug2991 | Placebo- 1.00 mg/kg Wiki | 1.00 |
| drug1279 | Drugs: NA-831 (0.10 mg/kg) plus GS-5734 (1.00 mg/kg) Wiki | 1.00 |
| drug1275 | Drug: NA-831 - 0.10 mg/kg Wiki | 1.00 |
| drug1280 | Drugs: NA-831 (0.20 mg/kg) plus GS-5734 (2.00 mg/kg) Wiki | 1.00 |
| drug1269 | Drug: GS-5734 - 1.00 mg/kg Wiki | 1.00 |
| drug1276 | Drug: NA-831 - 0.20 mg/kg Wiki | 1.00 |
| drug2929 | Placebo 0.10 mg + 1.00 mg/kg Wiki | 1.00 |
| drug2989 | Placebo- 0.10 mg/kg Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D009410 | Nerve Degeneration NIH | 0.71 |
| D012141 | Respiratory Tract Infections NIH | 0.16 |
| D014777 | Virus Diseases NIH | 0.11 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002180 | Neurodegeneration HPO | 0.71 |
| HP:0011947 | Respiratory tract infection HPO | 0.16 |
| HP:0002090 | Pneumonia HPO | 0.05 |
Navigate: Correlations HPO
There is one clinical trial.
Due to the COVID-19 pandemic in our country, individuals over 65 are prohibited from leaving their homes by T.C. The Ministry of Internal Affairs on March 21, 2020. While social isolation provides protection from COVID-19, it also brings some side effects that pose health risks. Studies investigating the relationship between social isolation and health behavior report that individuals with smaller social networks report less healthy diets, excessive alcohol consumption, and less physical activity. The effects of social isolation are related to physical inactivity, smoking. Physical activity is any body movement produced by the contraction of skeletal muscles that increases energy consumption. 150 minutes of moderate PA, 75 minutes of severe PA per week, or combined moderate and severe intensity PA plus twice a week strength training is recommended for elderly. The prevalence of physical inactivity increases significantly with increasing age. At the global level, approximately 45% of people over the age of 60 do not meet the recommended level of PA. The decrease in physical performance is associated with the risk of falling, sarcopenia, fragility, decreased quality of life, emotionalization, comorbidity, early death, and increased health care costs. The purpose of this study; to evaluate the physical activity level, functional capacity and quality of life of individuals over the age of 65 who socially isolated due to the precautions COVID-19 pandemic, and to investigate the effectiveness of video based home exercise program.
Description: Physical Activity Scale for the Elderly will use to assess the physical activity level of elderly individuals, the factors affecting the activity level, the relationship between physical activity and health profile. The minimum and maximum score that can be obtained from the scale is 0 and 400.The higher score indicates better level of physical activity.
Measure: Physical Activity Scale for the Elderly Time: 6 weeksDescription: Nottingham Health Profile will use to assess the quality of life related to health. It is a general quality of life questionnaire that assesses the level of individuals' health problems and how they affect their daily life activities. It have six subtitles, scored between 0-100. The high total score indicates that the health condition is bad.
Measure: Nottingham Health Profile Time: 6 weeksDescription: Short Physical Performance Battery will use to assess physical performance. This test consists of 3 objective tests that evaluate lower body function; 4 meters walking, getting up from the chair and standing balance test. 5-step (0-4) summary score is assigned for each test; higher scores show better physical performance.
Measure: Short Physical Performance Battery Time: 6 weeksDescription: Beck anxiety inventory will use to assess anxiety level. The survey includes substances that determine anxious temperament, autonomic hyperactivity and motor tension, some cognitions. The patient is asked to evaluate the symptoms within the 'last week including today'. Each symptom is evaluated as none, mild, moderate, and severe. The total score ranges from 0-63.
Measure: Beck anxiety inventory Time: 6 weeksDescription: Beck depression inventory will use to assess depression level. It consists of 21 items with an increasing score between 0-3. The total score ranges from 0-63.
Measure: Beck depression inventory Time: 6 weeksDescription: Contentment With Life Scale will use to assess satisfaction level. The questionnaire consists of 5 questions in total and each question has a threshold of evaluation from 5 to 25 points (5 points for the worst and 25 points for the best).
Measure: Contentment With Life Scale Time: 6 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports